Tag:
dry-powder technology
Latest Headlines
Latest Headlines
Aptar launches new inhaler with eye on emerging markets
Just in time for World Asthma Day, Aptar Pharma is launching a capsule-based dry powder inhaler.
Mylan to acquire Pfizer respiratory tech for $17.5M
Mylan ($MYL) will pay $17.5 million to acquire global development, manufacturing and commercialization rights to Pfizer's dry powder respiratory drug delivery system. Pending regulatory...
MicroDose proving itself to military as inhaled nerve-agent treatment
Drug delivery specialists MicroDose Therapeutx, based in Monmouth Junction, NJ, produces a device called the MicroDose DPI (dry powder inhaler), which uses piezoelectronics to deliver inhaled drugs.
MicroDose's dry powder inhaler incorporated into Novartis device
Drug delivery specialists MicroDose Therapeutx, based in Monmouth Junction, NJ, produces a device called the MicroDose DPI (dry powder inhaler), which uses piezoelectronics to deliver inhaled drugs.
Dry powder inhaler stays strong even if breath is weak
MedGadget blog tells us about a new dry powder inhaler that, according to Cambridge Consultants and India's Sun Pharma Advanced Research Company (SPARC), delivers an even drug dose deep into the
Savara gains $1.4M for pulmonary NanoCluster delivery
Savara Pharmaceuticals, based in Austin, Texas, has just collected $1.4 million from 23 investors, according to the Austin Business Journal. The company can add that to the $1.9 million it received
Savara wins $1.9M award for dry-powder tech
Austin-based Savara has picked up a $1.9 million award from the Texas Emerging Technology Fund to back its development of dry-powder versions of respiratory drugs. The award comes on top of $1.4
